On. Chappey et al., COLCHICINE DISPOSITION IN HUMAN-LEUKOCYTES AFTER SINGLE AND MULTIPLE ORAL-ADMINISTRATION, Clinical pharmacology and therapeutics, 54(4), 1993, pp. 360-367
Inasmuch as leukocytes were reported to be an active pharmacologic com
partment, colchicine disposition was determined in plasma, granulocyte
s, and mononuclear cells in healthy volunteers after 1 mg oral single
and multiple doses. After the single dose, maximal colchicine concentr
ation was observed at 1 hour in plasma and 47 hours later in leukocyte
s. This delay was confirmed by the slow accumulation of colchicine by
lymphocytes in culture. In the multiple-dose study, mean granulocyte c
olchicine concentration (20 to 53 ng/10(9) cells) were twofold higher
than in mononuclear cells (9 to 24 ng/10(9) cells). Mean predicted col
chicine multiple-dose granulocyte and mononuclear cell concentrations
were 2.5-fold and ninefold higher, respectively, than those measured.
After the last dose, colchicine decreased, with half-life values betwe
en 41 and 46 hours for leukocytes and 49 hours for plasma. This study
validates leukocytes as a microcompartment whose kinetics correlates w
ith colchicine biologic effects.